Same industry

MRNA against four biotech peers, a year at 100

100200400800Nov ’25FebMayAugNov ’26AMGN+43.8%GILD+41.0%BIIB+56.9%EXEL+68.4%MRNA×9.8

MRNA ×9.8. Exelixis +68.4%, Biogen +56.9%, Amgen +43.8%, Gilead Sciences +41.0%. Weekly closes, Nov 7, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in MRNA’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

MRNA: stories, the record and filings →